Evidence map›Paper›PMID 30718609›Full record

ArticleScientific reports2019

Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Alina C Stimmell, David Baglietto-Vargas, Shawn C Moseley, Valérie Lapointe, Lauren M Thompson, Frank M LaFerla, Bruce L McNaughton, Aaron A Wilber

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alina C StimmellDepartment of Psychology, Program in Neuroscience, Florida State University, Tallahassee, Florida, USA. astimmell@neuro.fsu.edu.
David Baglietto-VargasNeurobiology and Behavior, University of California Irvine, Irvine, California, USA.ORCID 0000-0003-1441-3175
Shawn C MoseleyDepartment of Psychology, Program in Neuroscience, Florida State University, Tallahassee, Florida, USA.
Valérie LapointeDepartment of Neuroscience, University of Lethbridge, Lethbridge, Alberta, Canada.
Lauren M ThompsonDepartment of Psychology, Program in Neuroscience, Florida State University, Tallahassee, Florida, USA.
Frank M LaFerlaNeurobiology and Behavior, University of California Irvine, Irvine, California, USA.
Bruce L McNaughtonNeurobiology and Behavior, University of California Irvine, Irvine, California, USA.
Aaron A WilberDepartment of Psychology, Program in Neuroscience, Florida State University, Tallahassee, Florida, USA. awilber@fsu.edu.

Funding

TISSUE REPOSITORY COREP01AG000538 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI GLABE, CHARLES G. · 1985 to 2018
$24.8M
Learning and Memory Impairments in Transgenic AD ModelsR01AG027544 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2007 to 2016
$3.1M
Parietal-hippocampal network in the triple transgenic mouse model of AlzheimersR00AG049090 · NIA · FLORIDA STATE UNIVERSITY · PI WILBER, AARON A · 2017 to 2019
$747k
Parietal-hippocampal network in the triple transgenic mouse model of AlzheimersK99AG049090 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI WILBER, AARON A · 2015 to 2016
$189k
NIA NIH HHS K99 AG049090NIA NIH HHS P01 AG000538NIA NIH HHS R00 AG049090NIA NIH HHS R01 AG027544
6 · The paper itself

Abstract

In early Alzheimer's disease (AD) spatial navigation is impaired; however, the precise cause of this impairment is unclear. Recent evidence suggests that getting lost is one of the first impairments to emerge in AD. It is possible that getting lost represents a failure to use distal cues to get oriented in space. Therefore, we set out to look for impaired use of distal cues for spatial orientation in a mouse model of amyloidosis (3xTg-AD). To do this, we trained mice to shuttle to the end of a track and back to an enclosed start box to receive a water reward. Then, mice were trained to stop in an unmarked reward zone to receive a brain stimulation reward. The time required to remain in the zone for a reward was increased across training, and the track was positioned in a random start location for each trial. We found that 6-month female, but not 3-month female, 6-month male, or 12-month male, 3xTg-AD mice were impaired. 6-month male and female mice had only intracellular pathology and male mice had less pathology, particularly in the dorsal hippocampus. Thus, AD may cause spatial disorientation as a result of impaired use of landmarks.

Indexed as

Alzheimer DiseaseAnimalsBehavior, AnimalBiomarkersDisease Models, AnimalFemaleGenotypeImmunohistochemistryMaleMiceMice, TransgenicSpace PerceptionBiomarkers

Identifiers

PMID30718609
PMCPMC6361963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.